Angel Guevara, molecular biologist and professor at the Central University of Ecuador (UCE), discusses Ecuador’s potential as a clinical trial destination, a diverse tropical country with high prevalence of infectious disease and educated healthcare professionals. He explains the differences between public and private healthcare services, notably from the point of view of quality and working capital cycle, as well as the benefits of an increase in public-private collaboration in scientific research.
Why is it interesting to study biology and parasitic diseases in Ecuador?
"One of the most recent reforms considering education, across the board, is the implementation of a leaving certificate test upon completion of one’s curriculum in higher education."
